Skip to content
Disclosery

13F-HR filed by RP Management, LLC

RP Management, LLC filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-13, with 3 holding rows worth $148,723,022.

Accession
0001507673-24-000002
Filer
CIK 1507673
Filed
2024-02-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2023

A holdings report, 3 entries on the cover page, a total value of $148,723,022 stated on the cover page (in dollars after the unit check, H1), rows summing to $148,723,022 with VALUE read as dollars as filed, 13F file number 028-19261. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BIOHAVEN LTDG1110E107COM2,936,507$125,682,450dollars as filed
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock3,846,154$23,038,463dollars as filed
VIRACTA THERAPEUTICS INC92765F108COM3,700$2,109dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001507673-24-000002this filing2024-02-13acceptance time not in the bulk data set